Review of tegaserod in the treatment of irritable bowel syndrome

Author： Patel Sonal   Berrada Driss   Lembo Anthony  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.11, 2004-11, pp. : 2369-2379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tegaserod effective in irritable bowel syndrome

By  

Inpharma, Vol. 1, Iss. 1313, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome

By McLaughlin John   Houghton Lesley A  

Expert Opinion on Drug Safety, Vol. 5, Iss. 2, 2006-03 ,pp. : 313-327

Informa Healthcare

Access to resources Recommend Favorite

Tegaserod: a new 5-HT4 agonist in the treatment of irritable bowel syndrome

By Tack Jan   Corsetti Maura  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1211-1218

Informa Healthcare

Access to resources Recommend Favorite

Tegaserod: A Review of its Use in the Management of Irritable Bowel Syndrome with Constipation in Women

By Wagstaff A.J.   Frampton J.E.   Croom K.F.  

Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. : 1101-1120

Adis International

Access to resources Recommend Favorite

Tegaserod relieves global symptoms of Irritable Bowel Syndrome

By  

Inpharma, Vol. 1, Iss. 1350, 2002-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite